Treatment of intracellular infection
US6660264B1 · kind B1 · utility
5Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2001 |
| Grant date | Dec 9, 2003 |
| Priority date | — |
| Expiry date | Nov 20, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An agent for combating an intracellular microbial infection comprises a phage component and, associated therewith, a targeting moiety which directs the agent to a target cell and initiates delivery of the phage into the target cell. Once inside the target cell, the phage causes lysis of a microorganism residing within the target cell. A mycobacteriophage is combined with a targeting moiety of transferrin. Compositions comprising the agent, methods of preparing said agent, and use of said agent for combating intracellular infections are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.